Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 12
Submit an article Journal homepage
369
Views
10
CrossRef citations to date
0
Altmetric
Infection: Original Article

Dose titration of intramuscular interferon beta-1a reduces the severity and incidence of flu-like symptoms during treatment initiation

Mark A. MatsonPRISM Research, Inc. St. Paul, MNUSA
,
Thomas R. Zimmerman JrBiogen Idec Inc. Weston, MAUSA
,
Dianne TuccilloBiogen Idec Inc. Weston, MAUSA
,
Yongqiang TangBiogen Idec Inc. Weston, MAUSA
&
Aaron DeykinBiogen Idec Inc. Weston, MAUSACorrespondence[email protected]
Pages 2271-2278 | Accepted 06 Oct 2011, Published online: 28 Oct 2011

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

John G. Devane, Mary L. Martin & Mark A. Matson. (2014) A short 2 week dose titration regimen reduces the severity of flu-like symptoms with initial interferon gamma-1b treatment. Current Medical Research and Opinion 30:6, pages 1179-1187.
Read now
Chiara Zecca, Nikhil Yawalkar & Claudio Gobbi. (2012) Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients. Patient Preference and Adherence 6, pages 565-567.
Read now

Articles from other publishers (8)

Yuan Zhao, Kun Chen, Nancy Ramia, Sangeeta Sahu, Achint Kumar, Maria L. Naylor, Li Zhu, Himanshu Naik & Cherié L. Butts. (2021) Bioequivalence of intramuscular and subcutaneous peginterferon beta-1a: results of a phase I, open-label crossover study in healthy volunteers. Therapeutic Advances in Neurological Disorders 14, pages 175628642097522.
Crossref
Robert T Naismith, Barry Hendin, Sibyl Wray, DeRen Huang, Fiorenza Gaudenzi, Qunming Dong, Bjørn Sperling, Monica Mann & Brian Werneburg. (2019) Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results. Multiple Sclerosis Journal - Experimental, Translational and Clinical 5:1, pages 205521731882214.
Crossref
Jiří Piťha. (2018) Glatiramer acetate in clinically isolated syndrome and its early onset of effect. Neurologie pro praxi 19:4, pages 262-266.
Crossref
Haruki Makioka, Fuyuki Nakaya, Yan Ling, Shinichi Torii, Takahiko Saida & Jun-ichi Kira. (2017) Safety and effectiveness of interferon β-1a intramuscular therapy: results of the postmarketing drug surveillance in Japan. Rinsho Shinkeigaku 57:10, pages 553-561.
Crossref
Martin Langeskov-Christensen, Tue Kjølhede, Egon Stenager, Henrik Boye Jensen & Ulrik Dalgas. (2016) Can aerobic exercise alleviate flu-like symptoms following interferon beta-1a injections in patients with multiple sclerosis?. Journal of the Neurological Sciences 365, pages 114-120.
Crossref
Takahiko Saida, Jun-ichi Kira, Yasuhiro Ueno, Naozumi Harada & Toshiyuki Hirakata. (2016) Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in Japanese patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 7, pages 102-108.
Crossref
Mary L. Filipi, Jill Beavin, Raquel T. Brillante, Kathleen Costello, Gail C. Hartley, Kay Hartley, Marie Namey, Shirley O'Leary & Gina Remington. (2014) Nurses’ Perspective on Approaches to Limit Flu-Like Symptoms During Interferon Therapy for Multiple Sclerosis. International Journal of MS Care 16:1, pages 55-60.
Crossref
Gina Remington, Yolanda Rodriguez, Diana Logan, Caroline Williamson & Katherine Treadaway. (2013) Facilitating Medication Adherence in Patients with Multiple Sclerosis. International Journal of MS Care 15:1, pages 36-45.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.